Converted thousands of passive investors into active, vocal supporters of a new biopharmaceutical company. Built and launched an ongoing email campaign (~3 years) to drive a 100K+ list of passive North America investors to a landing page then subsequently opt-in to a newsletter.
The buzz generated from the synergistic efforts accelerated the company’s
ability to go publicinternationally (CSXN and NASDAQ).